Cargando…
A new antagonist for CCR4 attenuates allergic lung inflammation in a mouse model of asthma
CCR4 is highly expressed on Th2 cells. CCR4 ligands include CCL22 and CCL17. Chemokine-like factor 1 can also mediate chemotaxis via CCR4. We designed and synthetized novel CCR4 antagonists, which were piperazinyl pyridine derivatives, for disrupting the interaction between three ligands and CCR4. W...
Autores principales: | Zhang, Yang, Wu, Yinfang, Qi, Hui, Xiao, Junhai, Gong, Hongwei, Zhang, Yan, Xu, Enquan, Li, Song, Ma, Dalong, Wang, Ying, Li, Wen, Shen, Huahao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678437/ https://www.ncbi.nlm.nih.gov/pubmed/29118379 http://dx.doi.org/10.1038/s41598-017-11868-9 |
Ejemplares similares
-
Publisher Correction: A new antagonist for CCR4 attenuates allergic lung inflammation in a mouse model of asthma
por: Zhang, Yang, et al.
Publicado: (2018) -
Design and Synthesis of a Series of Pyrido[2,3-d]pyrimidine Derivatives as CCR4 Antagonists
por: Gong, Hongwei, et al.
Publicado: (2012) -
Interleukin-22 attenuates allergic airway inflammation in ovalbumin-induced asthma mouse model
por: Wang, Jingru, et al.
Publicado: (2021) -
Effects of a dual CCR3 and H(1)-antagonist on symptoms and eosinophilic inflammation in allergic rhinitis
por: Greiff, Lennart, et al.
Publicado: (2010) -
Design, Synthesis and SAR Study of Novel Trisubstituted Pyrimidine Amide Derivatives as CCR4 Antagonists
por: Xu, Libao, et al.
Publicado: (2014)